XM n’offre pas ses services aux résidents des États-Unis d’Amérique.

Now is least-bad time for JPMorgan CEO to move on



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BREAKINGVIEWS-Now is least-bad time for JPMorgan CEO to move on</title></head><body>

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

By John Foley

NEW YORK, July 12 (Reuters Breakingviews) -Jamie Dimon missed JPMorgan’s JPM.N quarterly earnings call on Friday because he was traveling. That’s unusual: neither throat cancer nor an aortic dissection have stopped him before. However innocuous, his absence makes for a good dress rehearsal. This could be the least-bad time for the long-serving CEO of the near-$600 billion lender to initiate his exit.

JPMorgan on Friday reported the highest quarterly earnings of any bank in history. The $18 billion sum was boosted by a $6 billion gain on shares held in payments processor Visa V.N, but even without that, Dimon’s bank is serving high profit and low anxiety. Losses on credit cards stand at a roughly normal 3.5% of total outstanding borrowings. The bank’s common equity capital buffer is about $56 billion larger than regulators demand, giving ample room for dividends and buybacks.

This smooth road makes it easier for Dimon, now 18 years into his tenure, to name a successor. The two likeliest candidates, Marianne Lake and Jennifer Piepszak, both run well-performing divisions. Lake’s consumer bank made a return on equity of 30% in the quarter; Piepszak’s investment bank generated fee growth of over 50%. Rivals Citigroup C.N and Wells Fargo WFC.N also reported strong gains in dealmaking, suggesting the beginning of a broad bounce-back. Completed M&A is typically around 20% of GDP, according to Morgan Stanley analysts; in 2024’s first quarter, it ran at a rate of around 8%.

Dimon’s steady hand against this benign backdrop means his bank trades at 1.8 times forward book value, according to LSEG data, almost double the valuation of the banking industry overall. And the one big outstanding threat to the industry, the onerous retooling of Basel 3 capital rules, has been all but neutered.

While JPMorgan may be a bastion of stability, though, Dimon - who leans Democrat - has expressed concern about the state of the country. U.S. President Joe Biden’s weakness after a poor debate performance makes the people in his orbit all the more crucial, whether it’s a future Treasury Secretary or other senior economic advisory jobs. Dimon doesn’t want to run for president, but he clearly wants whoever does to be effective. That must increase the lure of a move to Washington.

There seems no rush, from investors or the board, for Dimon to leave JPMorgan. Left-leaning Democrats may not want him. But if the stars align, the cost of an orderly transition at the bank is as low as it’s ever been.

Follow @johnsfoley on X


CONTEXT NEWS

JPMorgan reported $18.1 billion of net income for the second quarter of 2024, the highest in the bank’s history. The figure was boosted by a $6 billion accounting gain from converting stock it holds in payments processor Visa from one class of shares into two new classes.

Revenue of $51 billion increased 20% year-on-year, including a 4% increase in net interest revenue, which makes up roughly half of the total. Investment banking fees, which include advising on mergers and underwriting stock and bond issues, increased 52%.

Citigroup, which reported a 10% rise in second-quarter earnings to $3.2 billion on the same day, said that investment banking fees increased 63% year-on-year. Wells Fargo reported a 70% increase. Both banks reported strong results across all major investment bank activities.


Graphic: JPMorgan's valuation lead over rivals looks secure https://reut.rs/4cOBafo


Editing by Jonathan Guilford and Sharon Lam

</body></html>

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques